Bone metastasis is a frequent occurrence in breast cancer, affecting more than 70% of late stage cancer patients with severe complications such as fracture, bone pain, and hypercalcemia. The pathogenesis of osteolytic bone metastasis depends on cross-communications between tumor cells and various stromal cells residing in the bone microenvironment. Several growth factor signaling pathways, secreted micro RNAs (miRNAs) and exosomes are functional mediators of tumor-stromal interactions in bone metastasis. We developed a functional genomic approach to systemically identified molecular pathways utilized by breast cancer cells to engage the bone stroma in order to generate osteolytic bone metastasis. We showed that elevated expression of vascular cell adhesion molecule 1 (VCAM1) in disseminated breast tumor cells mediates the recruitment of pre-osteoclasts and promotes their differentiation to mature osteoclasts during the bone metastasis formation. Transforming growth factor β (TGF-β) is released from bone matrix upon bone destruction, and signals to breast cancer to further enhance their malignancy in developing bone metastasis. We furthered identified Jagged1 as a TGF-β target genes in tumor cells that engaged bone stromal cells through the activation of Notch signaling to provide a positive feedback to promote tumor growth and to activate osteoclast differentiation. Substantially change in miRNA expression was observed in osteoclasts during their differentiation and maturation, which can be exploited as circulating biomarkers of emerging bone metastasis and therapeutic targets for the treatment of bone metastasis. Further research in this direction may lead to improved diagnosis and treatment strategies for bone metastasis.

Citations

Citations to this article as recorded by  

• Osteoclast Cancer Cell Metabolic Cross-talk Confers PARP Inhibitor Resistance in Bone Metastatic Breast Cancer
  Huijuan Fan, Zhanao Xu, Ke Yao, Bingxin Zheng, Yuan Zhang, Xuxiang Wang, Tengjiang Zhang, Xuan Li, Haitian Hu, Bin Yue, Zeping Hu, Hanqiu Zheng
  Cancer Research.2024; 84(3): 449.     CrossRef
• Bone Marrow Mesenchymal Stem Cells Restrain the Migration and Invasion of Breast Cancer Cells by Up-Regulating miR-2158 and Inactivating RAI2/NLRP3 Pathway
  Meiyu Xu, Shen Ye, Zhiqiang Tang, Shuai Gong
  Journal of Biomaterials and Tissue Engineering.2023; 13(1): 162.     CrossRef
• Association of RANKL and EGFR gene expression with bone metastases in patients with metastatic non-small cell lung cancer
  Anita J.W.M. Brouns, Lizza E.L. Hendriks, Iris J. Robbesom-van den Berge, Annemariek J.H.M. Driessen, Guido M.J.M. Roemen, Britt L.J. van Herpen, Zoë Dekkers, Bas Heitzer, Daphne J.G. Leunissen, Laura Moonen, Ragnar Lunde, Marcel Westenend, Marjolein van
  Frontiers in Oncology.2023;[Epub]     CrossRef
• BMAL1 induces colorectal cancer metastasis by stimulating exosome secretion
  Pengjuan Dong, Yaping Wang, Yutong Liu, Chunting Zhu, Jiaxin Lin, Ruizhe Qian, Luchun Hua, Chao Lu
  Molecular Biology Reports.2022; 49(1): 373.     CrossRef
• Chemokines network in bone metastasis: Vital regulators of seeding and soiling
  Gunjan Sharma, Ramesh Pothuraju, Ranjana Kumari Kanchan, Surinder Kumar Batra, Jawed Akhtar Siddiqui
  Seminars in Cancer Biology.2022; 86: 457.     CrossRef
• The Signaling Pathways Associated With Breast Cancer Bone Metastasis
  Xuelian Song, Changran Wei, Xiangqi Li
  Frontiers in Oncology.2022;[Epub]     CrossRef
• Effects of 8-week noncontinuous aerobic exercise on the levels of CCL2, CCL5, and their respective receptors in female BALB/C mice suffering from breast cancer
  Mehrnoosh Esmailiyan, Mehdi Kargarfard, Fahimeh Esfarjani, Golnaz Vaseghi
  International Journal of Preventive Medicine.2022; 13(1): 55.     CrossRef
• Non‐coding RNAs in bone remodelling and bone metastasis: Mechanisms of action and translational relevance
  Margherita Puppo, Hanna Taipaleenmäki, Eric Hesse, Philippe Clézardin
  British Journal of Pharmacology.2021; 178(9): 1936.     CrossRef
• Sympathetic activity in breast cancer and metastasis: partners in crime
  Francisco Conceição, Daniela M. Sousa, Joana Paredes, Meriem Lamghari
  Bone Research.2021;[Epub]     CrossRef
• Extracellular Vesicles in Tumors: A Potential Mediator of Bone Metastasis
  Shenglong Li, Wei Wang
  Frontiers in Cell and Developmental Biology.2021;[Epub]     CrossRef
• Bone marrow niches in the regulation of bone metastasis
  Fenfang Chen, Yujiao Han, Yibin Kang
  British Journal of Cancer.2021; 124(12): 1912.     CrossRef
• Exosomal miR-19a and IBSP cooperate to induce osteolytic bone metastasis of estrogen receptor-positive breast cancer
  Kerui Wu, Jiamei Feng, Feng Lyu, Fei Xing, Sambad Sharma, Yin Liu, Shih-Ying Wu, Dan Zhao, Abhishek Tyagi, Ravindra Pramod Deshpande, Xinhong Pei, Marco Gabril Ruiz, Hiroyuki Takahashi, Shunsuke Tsuzuki, Takahiro Kimura, Yin-yuan Mo, Yusuke Shiozawa, Ravi
  Nature Communications.2021;[Epub]     CrossRef
• Circulating Osteocalcin-Positive Cells as a Novel Diagnostic Biomarker for Bone Metastasis in Breast Cancer Patients
  Kyung-Hun Lee, Kyoung Jin Lee, Tae-Yong Kim, Febby Hutomo, Hyun Jin Sun, Gi Jeong Cheon, Serk In Park, Sun Wook Cho, Seock-Ah Im
  Journal of Bone and Mineral Research.2020; 35(10): 1838.     CrossRef
• Polymer nanomedicines
  Jindřich Kopeček, Jiyuan Yang
  Advanced Drug Delivery Reviews.2020; 156: 40.     CrossRef
• Osteolytic metastasis in breast cancer: effective prevention strategies
  Chandi C Mandal
  Expert Review of Anticancer Therapy.2020; 20(9): 797.     CrossRef
• The Tumor Microenvironment of Primitive and Metastatic Breast Cancer: Implications for Novel Therapeutic Strategies
  Giovanni Zarrilli, Gianluca Businello, Maria Vittoria Dieci, Silvia Paccagnella, Valentina Carraro, Rocco Cappellesso, Federica Miglietta, Gaia Griguolo, Valentina Guarneri, Marcello Lo Mele, Matteo Fassan
  International Journal of Molecular Sciences.2020; 21(21): 8102.     CrossRef
• Identification and validation of DOCK4 as a potential biomarker for risk of bone metastasis development in patients with early breast cancer
  Jules A Westbrook, Steven L Wood, David A Cairns, Kathryn McMahon, Renu Gahlaut, Helene Thygesen, Mike Shires, Stephanie Roberts, Helen Marshall, Maria R Oliva, Mark J Dunning, Andrew M Hanby, Peter J Selby, Valerie Speirs, Georgia Mavria, Robert E Colema
  The Journal of Pathology.2019; 247(3): 381.     CrossRef
• The Relationship between Exosomes and Cancer: Implications for Diagnostics and Therapeutics
  Wendy W. Weston, Timothy Ganey, H. Thomas Temple
  BioDrugs.2019; 33(2): 137.     CrossRef
• In Vivo Assessment of VCAM-1 Expression by SPECT/CT Imaging in Mice Models of Human Triple Negative Breast Cancer
  Montemagno, Dumas, Cavaillès, Ahmadi, Bacot, Debiossat, Soubies, Djaïleb, Leenhardt, Leiris, Dufies, Pagès, Hernot, Devoogdt, Perret, Riou, Fagret, Ghezzi, Broisat
  Cancers.2019; 11(7): 1039.     CrossRef
• Notch and breast cancer metastasis: Current knowledge, new sights and targeted therapy (Review)
  Yu Zhang, Zi‑Yan Xie, Xuan‑Tong Guo, Xing‑Hua Xiao, Li‑Xia Xiong
  Oncology Letters.2019;[Epub]     CrossRef
• NPNT promotes early-stage bone metastases in breast cancer by regulation of the osteogenic niche
  Dongsheng Wang, Chenglong Zhao, Liangliang Gao, Yao Wang, Xin Gao, Liang Tang, Kun Zhang, Zhenxi Li, Jing Han, Jianru Xiao
  Journal of Bone Oncology.2018; 13: 91.     CrossRef
• Placental exosomes: A proxy to understand pregnancy complications
  Jin Jin, Ramkumar Menon
  American Journal of Reproductive Immunology.2018;[Epub]     CrossRef
• Understanding the Bone in Cancer Metastasis
  Jaime Fornetti, Alana L Welm, Sheila A Stewart
  Journal of Bone and Mineral Research.2018; 33(12): 2099.     CrossRef
• Role of Tumor-Derived Chemokines in Osteolytic Bone Metastasis
  Salvatore J. Coniglio
  Frontiers in Endocrinology.2018;[Epub]     CrossRef
• The role of exosomes in cancer metastasis
  Teresa Bernadette Steinbichler, József Dudás, Herbert Riechelmann, Ira-Ida Skvortsova
  Seminars in Cancer Biology.2017; 44: 170.     CrossRef
• Articles inEndocrinology and Metabolismin 2016
  Won-Young Lee
  Endocrinology and Metabolism.2017; 32(1): 62.     CrossRef
• Impaired Bone Matrix Alignment Induced by Breast Cancer Metastasis
  Aiko Sekita, Aira Matsugaki, Takayoshi Nakano
  Journal of the Japan Institute of Metals.2017; 81(6): 308.     CrossRef
• SMURF2 regulates bone homeostasis by disrupting SMAD3 interaction with vitamin D receptor in osteoblasts
  Zhan Xu, Matthew B. Greenblatt, Guang Yan, Heng Feng, Jun Sun, Sutada Lotinun, Nicholas Brady, Roland Baron, Laurie H. Glimcher, Weiguo Zou
  Nature Communications.2017;[Epub]     CrossRef
• Bone Microenvironment and Role of Rank-Rankl-Opg in Breast Cancer Metastasis in Bone
  Hongwei Zhang
  Journal of Cancer Prevention & Current Research.2017;[Epub]     CrossRef
• Tumor–Stroma Interactions in Bone Metastasis: Molecular Mechanisms and Therapeutic Implications
  Hanqiu Zheng, Wenyang Li, Yibin Kang
  Cold Spring Harbor Symposia on Quantitative Biology.2016; 81: 151.     CrossRef
• Breast cancer cells obtain an osteomimetic featureviaepithelial-mesenchymal transition that have undergone BMP2/RUNX2 signaling pathway induction
  Cong-Cong Tan, Gui-Xi Li, Li-Duan Tan, Xin Du, Xiao-Qing Li, Rui He, Qing-Shan Wang, Yu-Mei Feng
  Oncotarget.2016; 7(48): 79688.     CrossRef
• Heterotypic models of osteosarcoma recapitulate tumor heterogeneity and biological behavior
  Milcah C. Scott, Hirotaka Tomiyasu, John R. Garbe, Ingrid Cornax, Clarissa Amaya, M Gerard O'Sullivan, Subbaya Subramanian, Brad A. Bryan, Jaime F. Modiano
  Disease Models & Mechanisms.2016;[Epub]     CrossRef
• Osteoblasts Are the Centerpiece of the Metastatic Bone Microenvironment
  Hyo Min Jeong, Sun Wook Cho, Serk In Park
  Endocrinology and Metabolism.2016; 31(4): 485.     CrossRef

Citations

Citations to this article as recorded by  

• Voluntary Wheel Running Partially Compensates for the Effects of Global Estrogen Receptor-α Knockout on Cortical Bone in Young Male Mice
  Rebecca K. Dirkes, Nathan C. Winn, Thomas J. Jurrissen, Dennis B. Lubahn, Victoria J. Vieira-Potter, Jaume Padilla, Pamela S. Hinton
  International Journal of Molecular Sciences.2021; 22(4): 1734.     CrossRef
• Role of Osteocytes in Cancer Progression in the Bone and the Associated Skeletal Disease
  Manish Adhikari, Jesús Delgado-Calle
  Current Osteoporosis Reports.2021; 19(3): 247.     CrossRef
• Gestational and lactational exposure to BPA or BPS has minimal effects on skeletal outcomes in adult female mice
  Rebecca K. Dirkes, Rebecca J. Welly, Jiude Mao, Jessica Kinkade, Victoria J. Vieira-Potter, Cheryl S. Rosenfeld, Pamela S. Bruzina
  Bone Reports.2021; 15: 101136.     CrossRef
• Modulation of bone turnover aberration: A target for management of primary osteoporosis in experimental rat model
  Enas A. Fouad-Elhady, Hadeer A. Aglan, Rasha E. Hassan, Hanaa H. Ahmed, Gilane M. Sabry
  Heliyon.2020; 6(2): e03341.     CrossRef
• Aromatase inhibitors attenuate the effect of alendronate in women with breast cancer
  Sung Hye Kong, Jung Hee Kim, Sang Wan Kim, Chan Soo Shin
  Journal of Bone and Mineral Metabolism.2020; 38(5): 730.     CrossRef
• Global estrogen receptor-α knockout has differential effects on cortical and cancellous bone in aged male mice
  Rebecca K. Dirkes, Nathan C. Winn, Thomas J. Jurrissen, Dennis B. Lubahn, Victoria J. Vieira-Potter, Jaume Padilla, Pamela S. Hinton, Vance L. Trudeau
  FACETS.2020; 5(1): 328.     CrossRef
• The Emerging Role of Osteocytes in Cancer in Bone
  Emily G Atkinson, Jesús Delgado‐Calle
  JBMR Plus.2019;[Epub]     CrossRef
• Effect of denosumab on low bone mineral density in postmenopausal Japanese women receiving adjuvant aromatase inhibitors for non-metastatic breast cancer: 24-month results
  Katsuhiko Nakatsukasa, Hiroshi Koyama, Yoshimi Ouchi, Hisako Ono, Kouichi Sakaguchi, Takayuki Matsuda, Makoto Kato, Takashi Ishikawa, Kimito Yamada, Mana Yoshimura, Kei Koizumi, Teruhisa Sakurai, Hideo Shigematsu, Shunji Takahashi, Shinichiro Taira, Masat
  Breast Cancer.2019; 26(1): 106.     CrossRef
• Association of Wnt Inhibitors, Bone Mineral Density and Lifestyle Parameters in Women with Breast Cancer Treated with Anastrozole Therapy
  Kristina Bojanić, Ines Bilić Ćurčić, Lucija Kuna, Tomislav Kizivat, Robert Smolic, Nikola Raguž Lučić, Kristina Kralik, Vatroslav Šerić, Gordana Ivanac, Sandra Tucak-Zorić, Aleksandar Včev, Martina Smolić
  Journal of Clinical Medicine.2018; 7(9): 287.     CrossRef
• Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO, IMS, and SIOG
  Peyman Hadji, Matti S. Aapro, Jean-Jacques Body, Michael Gnant, Maria Luisa Brandi, Jean Yves Reginster, M. Carola Zillikens, Claus-C. Glüer, Tobie de Villiers, Rod Baber, G. David Roodman, Cyrus Cooper, Bente Langdahl, Santiago Palacios, John Kanis, Nass
  Journal of Bone Oncology.2017; 7: 1.     CrossRef
• Effects of raloxifene against letrozole-induced bone loss in chemically-induced model of menopause in mice
  Abul Kalam, Sushama Talegaonkar, Divya Vohora
  Molecular and Cellular Endocrinology.2017; 440: 34.     CrossRef
• Sclerostin: an Emerging Target for the Treatment of Cancer-Induced Bone Disease
  Michelle M. McDonald, Jesus Delgado-Calle
  Current Osteoporosis Reports.2017; 15(6): 532.     CrossRef
• Differential profile of letrozole and exemestane on bone turnover markers in vinylcyclohexene diepoxide treated ovotoxic female mice
  Abul Kalam, Sushama Talegaonkar, Divya Vohora
  Fundamental & Clinical Pharmacology.2016; 30(5): 429.     CrossRef
• Osteoblasts Are the Centerpiece of the Metastatic Bone Microenvironment
  Hyo Min Jeong, Sun Wook Cho, Serk In Park
  Endocrinology and Metabolism.2016; 31(4): 485.     CrossRef